WALTHAM, Mass.--(BUSINESS WIRE)--EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the ...
Climate Change, Urbanization, International Travel and Ecological Shifts Key Factors Behind Expansion of Dengue Transmission Zones Globally India remains highly vulnerable due to climatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results